Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
Early Parkinson's Treatment: AAN Issues New Guidelines Levodopa usually is best first therapy for motor symptoms, neurology group says Nov 15, 2021
Peak VO2 Improved After Beta-Blocker Withdrawal in Some HFpEF Patients Beta-blockers may not benefit HFpEF patients with chronotropic incompetence Nov 15, 2021
Aspirin Flops Again for Dementia Prevention ASCEND trial sides with ASPREE, but can't rule out some potential benefit Nov 15, 2021
Stem Cells Don't Prevent Acute Heart Failure Events DREAM-HF trial does hold some positive signals, though Nov 15, 2021
Two Anticoagulants -- When Used Correctly -- Similarly Protective Against Dementia GIRAF trial tested warfarin versus dabigatran in older Afib patients Nov 14, 2021
AMA Delegates Spar Over Medicare Drug Price Negotiation Some worry this could lead to price controls for physician services Nov 14, 2021
Tricuspid Repair Boosts Mitral Valve Surgery Outcomes Randomized trial supports combined surgery for moderate regurgitation Nov 13, 2021
Delaying Surgery Hurts Patients With Silent Aortic Stenosis Early aortic valve replacement wins in AVATAR trial Nov 13, 2021
Young Physicians Need Support From Organized Medicine, Says AMA President "The fear and weariness ... I'd call it battle fatigue" Nov 13, 2021
Biologic Disappoints for Arthritis Achilles' Inflammation But phase III trial did find some patient-oriented benefits Nov 11, 2021
Should Medicare Pay the Same Amount Regardless of Where a Service Is Provided? MedPAC members like the idea -- with a few caveats Nov 10, 2021
Vitamin D and Disease Prevention: Worth Another Look? Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
One Aducanumab Patient, Six Brain Edema Episodes "Uniquely complicated course" for patient treated with new Alzheimer's drug Nov 08, 2021
Early Biologics Better in Juvenile Idiopathic Arthritis After 2 years, more patients on combo biologic/DMARD regimen had inactive disease Nov 08, 2021
Pulmonary Pressure Monitoring Helps HFpEF Too GUIDE-HF substudy supports similar benefits across the ejection fraction spectrum Nov 07, 2021
Is LAA Closure With Amulet Less Leaky? Two studies, IDE and SWISS-APERO, come to disparate conclusions Nov 07, 2021
More Good News for Empagliflozin in Patients With Heart Failure Slower renal function decline with SGLT-2 inhibitor in EMPEROR-Preserved trial Nov 06, 2021
Longstanding Vascular Closure Technique Triumphs Over Collagen Plug Manta versus ProGlide after transfemoral TAVR in CHOICE-CLOSURE Nov 06, 2021
Investigational Oral CKD-Anemia Agent Effective, Safe HIF-PHI daprodustat increased hemoglobin without hurting heart Nov 05, 2021
LAA Closure Holds Up Against NOACs Longer-term follow-up from the PRAGUE-17 trial reassures Nov 05, 2021
FDA Panel Shows Little Love for Prader-Willi Drug Candidate All but one committee member said phase III evidence for carbetocin nasal spray was insufficient Nov 05, 2021
TAVR Operators Divided on Need for Bicuspid RCT Odds of a study coming to fruition are low Nov 05, 2021
Diuretic Bolstered Blood Pressure Control in Advanced CKD But some safety signals did arise in 12-week trial Nov 05, 2021
Adenosine-Free Alternative to FFR Bolstered by Longer-Term Data Physiological index boasts good 5-year results in iFR-SWEDEHEART Nov 05, 2021
Focused Ultrasound Approved for Advanced Parkinson's Expanded indication includes medication-refractory PD patients with motor problems Nov 05, 2021
Final Physician Fee Schedule Rule Includes a Nearly 4% Payment Cut Will leave practices in "financial peril," says AMA president Nov 03, 2021
Improvements in Treatment-Resistant Depression With Esketamine Pooled data from randomized trials showed better scores on the PHQ-9 as well Nov 02, 2021
Migraine Drug Shows Benefit for Those With Comorbid Depression, Anxiety Real-world study of fremanezumab found that patients were able to reduce antidepressant use Nov 01, 2021
Guillain-Barre Risk Up Slightly After Shingrix Findings support FDA warning for recombinant zoster vaccine Nov 01, 2021
Michigan EDs See Jump in Cannabis-Related Neuropsychiatric Toxicity Community-based study reports "troublesome" data in state that legalized marijuana for adults Oct 30, 2021
Biden Announces Deal With Congress on Infrastructure Bill Medicare hearing benefits make the cut, but dental, vision, drug-pricing provisions are left out Oct 28, 2021
Midlife Women With Declining Eyesight: Are They Also Looking at Future Depression? Varying degrees of visual impairment tied to depressive symptoms Oct 27, 2021
No Love for PRP in Ankle Osteoarthritis Trial Dutch researchers throw cold water on popular therapy Oct 26, 2021
Too Many TAVR Centers Are Clustered Around Well-to-Do Communities More centers not the answer to geographic, socioeconomic disparities in access? Oct 22, 2021
How Should Patients With Autoimmune Diseases Approach COVID Vaccination? Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
Ho-Hum Oral Presentations on COPD Turn Into Fascinating Roundtable Here's why online meetings can be great Oct 22, 2021
CDC Panel Champions 'Mix and Match' Booster Strategy Unanimous vote for boosters in certain groups, without specifying which vaccine they should be Oct 21, 2021
No Benefit to Intensifying Diabetes Meds at Hospital Discharge Older adults discharged with intensified regimen had higher risk of severe hypoglycemia Oct 21, 2021
